Losing More Hair ("If Winter Comes" No. 19)
AJ said that he notices hair coming off, but its not like in chunks or anything. If I look at his head, I can't tell that there are any hairs missing :).
He went to see Dr. H today, told me I didn't have to come and of course it feels weird when I am not there. I feel like I always have 100 questions to ask and want to make sure we get answers. So I sent a bunch of stick it notes with questions for him to ask instead :). It was just a check up and Dr. H said the same thing as Dr. F yesterday, he is responding well and so far so good.
Since he is going to receive CHOP in the bone marrow too now, he will go for the IV on Thursday at Dr H's office and then to Seton (hospital) to get it in the bone marrow. The reason for doing the bone marrow as well as IV is just to cover all bases basically.
Tomorrow morning is 'port cath' day. We have to be at the medical center at 9.30 for surgery at 11am. The nurse there said he should be done and out around 1.30pm. I know Aj thinks its a little weird doing this port thing, I'm sure it will take a little bit getting used to.
More tomorrow …
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
